Item 2.02 Results of Operations and Financial Condition.On October 9 2024 10x Genomics Inc. issued a press release announcing preliminary select third quarter results for the period ended September 30 2024. A copy of the press release is attached hereto as Exhibit 99.1.The information furnished pursuant to Item 2.02 in this Current Report on Form 8-K and the press release attached as Exhibit 99.1 hereto shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934 as amended (the Exchange Act) or otherwise subject to the liabilities of that section nor shall it be deemed incorporated by reference into any other filing under the Securities Act of 1933 as amended or the Exchange Act except as expressly set forth by specific reference in such a filing..